ILLUSIO is a plastic surgery simulation tool that enables a surgeon and patient to have a visual discussion about all of the possible outcomes of breast augmentation. Our revolutionary artistic platform gives the surgeon the perfect opportunity to create the ideal size and shape for every possible situation. The best part is that now the surgeon and patient will share the same visual expectation of surgery, and equally important, have a mutual understanding of the limitations of surgery based on the patients unique anatomy. Remember, ILLUSIO is primarily an artistic tool created to manage patient expectations. With ILLUSIO, the overall time per consult could become shorter and patients could make decisions quicker and with much more confidence. Above all, they will have fun with the process. The ability to look into our Virtual Mirror and see themselves with their virtual breasts is new and exciting and provides a real Wow experience. As patients become engaged in the process they will very likely want to share their ILLUSIO experience with their friends and family. Source
No articles found.
NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...
NeuBase Therapeutics, Inc. is developing its mo...
Sanofi is dedicated to supporting people through their health challenges. We are a...
Sanofi is dedicated to supporting people throug...
HJLI specializes in developing and manufacturing bioprosthetic medical devices to ...
HJLI specializes in developing and manufacturin...
Quadrant Biosciences is an epigenetic diagnostics company with a focus on the earl...
Quadrant Biosciences is an epigenetic diagnosti...
IRADIMED CORPORATION is a leader in the development of innovative magnetic resonan...
IRADIMED CORPORATION is a leader in the develop...
Histogenics historically focused on the development of restorative cell therapies,...
Histogenics historically focused on the develop...
Remark Holdings (NASDAQ: MARK) primarily focuses on the development and deployment...
Remark Holdings (NASDAQ: MARK) primarily focuse...
Join the National Investor Network and get the latest information with your interests in mind.